The Center for Technology Licensing (CTL) is Cornell University's technology transfer office. We manage technology for Cornell's Ithaca campus, Weill Cornell Medicine, Cornell Tech, and Cornell AgriTech in Geneva.
The Center for Technology Licensing (CTL) at Cornell University launched a new site to showcase COVID-19 related innovations available for commercialization and opportunities to connect and collaborate with researchers. ... Read More
Invention Summary Drug candidates to treat COVID-19 and a high throughput drug screening platform. Technology Overview The current COVID-19 pandemic has affected over 6 million people worldwide, has resulted in... Read More
Invention Summary Novel drug use and drug screening system for SARS-CoV-2 therapies. Technology Overview The outbreak of coronavirus disease COVID-19 caused by the novel SARS-CoV-2 virus has wreaked havoc... Read More
Invention Summary A platform of anti-inflammatory polymeric biomaterials that provides tunable immune responses via the modulation of macrophage metabolism. Technology Overview Macrophages (a type of white blood cell) produce... Read More
Invention Summary Nucleic acid amplification techniques are commonly used to diagnose viral diseases and determine when those who are sick remain capable of shedding/transmitting the virus. However, currently available methods... Read More